Document is current
Any future updates will be listed below
-
Authors
Bohne, Ann-Sophie https://orcid.org/0000-0003-3234-4281
Heber, Marilena
Axt, Franziska
von Bubnoff, Nikolas
Kähler, Katharina
-
Funding
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
- License Information
-
More Information
Article History
Received: 25 January 2026
Accepted: 2 April 2026
First Online: 9 May 2026
Declarations
:
: Dr Bohne has received travel grants from Sun Pharma, Pierre-Fabre and Bristol-Myers Squibb outside the submitted work. Mrs Heber has no conflicts of interest to report. Dr Kähler serves as consultant to Philogen, BMS, MSD, Sanofi Aventis, Immunocore and received travel grants and speaker fees from Philogen, Pierre Fabre, BMS, MSD, Sun Pharma, Sanofi Aventis, Novartis, Medac. Dr von Bubnoff received honoraria from Janssen, Novartis and BMS and travel expenses from Janssen.
: An abstract containing part of the submitted data has been presented as poster at the DGHO Meeting in 2022 and at the ADO meeting in 2022.
: The study was performed in line with the principlesof the Declaration of Helsinki. This study was approved by the ethics committee Kiel (Ethics vote D 431/06).
: Written informed consent was obtained from all individual participants included in the study.
